Biological Consequences of Prenatal Stress and/or Antidep
Biological Consequences of Prenatal Stress and/or Antidep
批准号:
7931869
负责人:
MICHAEL JOSEPH OWENS
金额:
$34.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2012-07-31
关键词:
AddressAdultAgeAntidepressive AgentsArtsBehaviorBiochemicalBiochemical MarkersBiologicalBiologyBirthBlood VesselsBrainBrain regionCaringDNA MethylationDevelopmentEpigenetic ProcessEventExposure toGenesGeneticGenomeGrowth FactorHealthHumanInfantLifeMeasuresMedicalMolecularMolecular ProfilingMonitorMorphologyMothersNeuraxisNeurobiologyNeurogliaNeuronsPathway interactionsPerinatalPerinatal ExposurePhysiologicalPromoter RegionsRattusSelective Serotonin Reuptake InhibitorSignal TransductionStressSynapsesSystemTechniquesTechnologyTestingVascular blood supplyabstractinghistone modificationin uteroinsightmRNA Expressionmaternal stressneurochemistryoffspringprenatal exposureprenatal stressreproductivestressor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT 4 - Abstract
Given the reality that human infants can be exposed to stressors and antidepressant drugs in utero as
part of life events or appropriate medical treatment of the mother, the long term developmental
consequences on the offspring need to be determined as one aspect of planning and monitoring long term
health issues. This project focuses upon the biological consequences (biochemical, molecular, physiological
and genetic) of the quality of maternal care interacting with prenatal stress and in utero antidepressant
exposure on brain function of offspring when these rats become adults of reproductive age (i.e., does
prenatal exposure to these factors alter the long term biology of the brain?). This project will focus on three
unique aspects of adult brain function. 1) What are the regional brain neurochemical and molecular changes
that result (the markers to be examined have all been previously promulgated, but not tested, to be involved
in stress responsivity or the mechanisms of action of antidepressants) from maternal care, prenatal stress
exposure, and in utero antidepressant exposure? 2) Are there structural changes in the microvascular
system supplying blood to the brain or in the angiogenic growth factors that signal new blood vessel
formation and retraction? For example, although.it is well established that CMS plasticity includes changes
in synaptic morphology, neuronal connectivity, glial morphology and function as well as changes in
vasculature, the effects of maternal care, early life stressors, and in utero antidepressant treatment on the
CNS have only been addressed for neurons and glia. 3) We will attempt to identify genetic loci that are
epigenetically altered by the quality of maternal care, prenatal stress, and in utero exposure to
antidepressants in rat brains. We will use ChlP-on-chip technology to investigate how the quality of maternal
care, prenatal stress, and in utero exposure to SSRI's alter the epigenetic profiles (both DNA methylation
and histone modification) of the promoter regions across the genome in rat brains at birth and in adulthood.
In addition, the mRNA expression profiles from the same brain regions will be evaluated and correlated with
the epigenetic profiles. These state-of-the-art techniques can offer unique insight into the long term
changes, or lack thereof, produced by differences in maternal care, prenatal stress, and in utero
antidepressant exposure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prenatal atypical antipsychotic exposure
-
批准号:8411507
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:9284284
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:9069456
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:8843911
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:8675273
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Biological Consequences of Prenatal Stress and/or Antidep
-
批准号:8111196
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2010
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Secondary Research Project: Monoamine Transporter Occupancy
-
批准号:8119601
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2010
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Research Methods Core
-
批准号:8119603
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2010
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Secondary Research Project: Monoamine Transporter Occupancy
-
批准号:7892513
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2009
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Research Methods Core
-
批准号:7892515
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2009
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Serotoninergic systems
-
批准号:6341042
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2000
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Serotoninergic systems
-
批准号:6259200
-
项目类别:
-
资助金额:$23.19万
-
财政年份:1999
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Serotoninergic systems
-
批准号:6324758
-
项目类别:
-
资助金额:$23.19万
-
财政年份:1999
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
NEUROCHEMICAL PATHOLOGY OF HUMAN COCAINE ABUSE
-
批准号:2122773
-
项目类别:
-
资助金额:$28.34万
-
财政年份:1995
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
NEUROCHEMICAL PATHOLOGY OF HUMAN COCAINE ABUSE
-
批准号:2430051
-
项目类别:
-
资助金额:$28.12万
-
财政年份:1995
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2121375
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2121372
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2121374
-
项目类别:
-
资助金额:$10.88万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2770093
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2517921
-
项目类别:
-
资助金额:$10.46万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
海外基金